Knopp Biosciences

Knopp Biosciences, a drug development and discovery company, leverages its innovation, experience and strategic partnerships to deliver breakthrough treatments for unmet medical needs. The company’s research focuses on delivering high-impact treatments for amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease), Parkinson’s disease and other neurodegenerative disorders.

Additional research focuses on delivering high-impact treatments for Parkinson’s disease and other neurodegenerative disorders. An experienced team of drug discovery, development and commercialization executives leads Knopp, while the company’s dexpramipexole development is guided by some of the world’s leading authorities on ALS.

Pittsburgh, PA